Jyong Biotech Ltd. Ordina...

NASDAQ: MENS · Real-Time Price · USD
47.65
6.07 (14.60%)
At close: Aug 20, 2025, 3:58 PM
48.00
0.73%
Pre-market: Aug 21, 2025, 04:20 AM EDT

Jyong Biotech Ordinary Shares Balance Sheet Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q4 2024 Q2 2024 Q4 2023
Period Ending Dec 31, 2024 Jun 30, 2024 Dec 31, 2023
Cash & Equivalents
98K 96K 177K
Short-Term Investments
n/a n/a n/a
Long-Term Investments
n/a n/a n/a
Other Long-Term Assets
2.97M 2.9M 2.87M
Receivables
n/a n/a n/a
Inventory
n/a n/a n/a
Other Current Assets
108K 104K 1.66M
Total Current Assets
206K 200K 1.84M
Property-Plant & Equipment
3.19M 3.34M 3.54M
Goodwill & Intangibles
n/a n/a n/a
Total Long-Term Assets
6.16M 6.24M 6.41M
Total Assets
6.37M 6.44M 8.25M
Account Payables
3K 9K 2K
Deferred Revenue
n/a n/a n/a
Short-Term Debt
7.28M 7.46M 7.97M
Other Current Liabilities
3.33M 3.31M 4.99M
Total Current Liabilities
12.13M 11.93M 14.26M
Long-Term Debt
10.68M 9.67M 8.52M
Other Long-Term Liabilities
20.06M 19.68M 19.47M
Total Long-Term Liabilities
30.76M 29.43M 28.06M
Total Liabilities
42.88M 41.37M 42.32M
Total Debt
18.14M 17.37M 16.69M
Common Stock
1K 1K 1K
Retained Earnings
-33.08M -31.39M -30.06M
Comprehensive Income
1.12M 1.02M 548K
Shareholders Equity
-36.52M -34.93M -34.07M
Total Investments
n/a n/a n/a